- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Industry Trends, Policy Challenges, and Educational Initiatives with Joseph Panetta
Joseph Panetta, President and CEO of Biocom California, shares his insights on biotech industry trends, policy challenges, and educational initiatives, drawing from over 25 years of leadership in California’s thriving life sciences sector.
Joseph Panetta, the President and CEO of Biocom California, sat down with Pharmaceutical Executive for an in-depth discussion on the state of the biotech industry. With over 25 years of experience leading the organization, Panetta provided a unique perspective on the emerging trends, policy challenges, and educational initiatives shaping the sector. From the industry's shifting funding landscape and the growing role of artificial intelligence to Biocom's strategic plans for global expansion and workforce development, this interview hits on key issues facing California's thriving life sciences community.
- 00:00 - Panetta's career journey and early work in the biotech industry
- 00:44 - Highlights of Panetta's 25-year tenure growing Biocom California
- 03:38 - Emerging trends in the biotech industry, including funding and use of AI
- 05:03 - Impact of the Inflation Reduction Act on the biotech industry
- 07:44 - Potential impact of the Biodefense Security Act on the biotech industry
- 09:39 - Advice for early-stage biotech companies seeking funding
- 10:44 - Biocom's 10-year strategic plan and goals
- 12:30 - Hopes and aspirations for improving patient care in the industry
- 14:38 - Biocom's educational initiatives, including Generation STEAM and Biocom California Institute
